David Nabarro, British physician who led UN response to Ebola and COVID-19, dies
Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, confirmed Nabarro's death on social media platform X.
'David was a great champion of global health and health equity, and a wise, generous mentor to countless individuals,' Tedros wrote Saturday. 'His work touched and impacted so many lives across the world.'
King Charles
knighted Nabarro in 2023 for his
contributions to global health
after he served as
one of six special envoys
to the WHO on COVID-19. He won the
2018 World Food Prize
for his work on health and hunger issues.
He also was a candidate for the
top job at the WHO in 2017
but lost out to
Tedros in the final round of voting.
Nabarro left the U.N. later that year.
The 4SD Foundation, a social enterprise in Switzerland focused on mentoring the next generation of leaders in global sustainable development, said its strategic director died at his home Friday in a 'sudden passing.' Other details were not immediately available.
'David's generosity and unwavering commitment to improve the lives of others will be sorely missed,' the foundation wrote on its website Saturday.
Survivors include his wife, Flo, as well as his five children and seven grandchildren.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
5 Billion Sea Stars Have Shattered and Died Over the Past 10 Years, Scientists May Finally Know Why
A team of international researchers discovered the cause of a sea-star wasting diseaseNEED TO KNOW The cause of a sea star-wasting disease was determined to be a bacterium known as Vibrio pectenicida The disease causes sea stars to disintegrate to death in a white, goo-like substance An estimated 95% of sunflower sea stars died during the 10-year epidemicAfter an estimated 5 billion sea stars died due to a wasting disease in oceans globally, scientists have identified the root cause of the disease. A team of researchers identified the cause as a bacterium known as Vibrio pectenicida. The team reported its findings this week in Nature Ecology & Evolution. The disease causes starfish to disintegrate into a white, slimy substance. The disease is the largest documented epidemic for a noncommercial species, and it has affected more than 20 species of sea stars along the West Coast of North America, Scientific American reports. An estimated 90% of sunflower sea stars ( known as Pycnopodia helianthoides) have died from the illness, making them a critically endangered species. Sunflower sea stars are capable of sprouting 24 arms and growing to the size of a bicycle tire, per the Associated Press. The epidemic has lasted a decade. The same strain of bacteria has also infected shellfish. The international research project was led by scientists from the Hakai Institute, the University of British Columbia (UBC), and the University of Washington—and conducted in collaboration with The Nature Conservancy, the Tula Foundation, the U.S. Geological Survey's Western Fisheries Research Center, and the Washington Department of Fish and Wildlife. The first author on the study and an evolutionary ecologist at the Hakai Institute and UBC, Melanie Prentice, told Tula: "When we lose billions of sea stars, that really shifts the ecological dynamics.' Prentice went on to describe the impact of losing a sea star. 'In the absence of sunflower stars, sea urchin populations increase, which means the loss of kelp forests, and that has broad implications for all the other marine species and humans that rely on them," she explained. "So losing a sea star goes far beyond the loss of that single species.' Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. With the sharp decline in sea stars, the sea urchins that usually serve as a food source rapidly expanded in population. In turn, they ate nearly 95% of the kelp forests in Northern California within a decade. These kelp forests help provide food and habitats for a wide variety of marine life, including fish, sea otters and seals, per the AP. With these new findings, researchers are hoping to revive the sea star population and restore balance to the ecosystem, the outlet reported. Read the original article on People
The Hill
3 hours ago
- The Hill
ACA premiums set to spike
The proposed rates are preliminary and could change before being finalized in late summer. The analysis includes proposed rate changes from 312 insurers in all 50 states and DC. It's the largest rate change insurers have requested since 2018, the last time that policy uncertainty contributed to sharp premium increases. On average, ACA marketplace insurers are raising premiums by about 20 percent in 2026, KFF found. Insurers said they wanted higher premiums to cover rising health care costs, like hospitalizations and physician care, as well as prescription drug costs. Tariffs on imported goods could play a role in rising medical costs, but insurers said there was a lot of uncertainty around implementation, and not many insurers were citing tariffs as a reason for higher rates. But they are adding in higher increases due to changes being made by the Trump administration and Republicans in Congress. For instance, the majority of insurers said they are taking into account the potential expiration of enhanced premium tax credits. Those subsidies, put in place during the COVID-19 pandemic, are set to expire at the end of the year, and there are few signs that Republicans are interested in tackling the issue at all. If Congress takes no action, premiums for subsidized enrollees are projected to increase by over 75 percent starting in January 2026, according to KFF. But some states are pushing back. Arkansas Gov. Sarah Huckabee Sanders (R) on Wednesday called on the state's insurance commissioner to disapprove the proposed increases from Centene and Blue Cross Blue Shield. The companies filed increases of up to 54 percent and 25.5 percent, respectively, she said. 'Arkansas' Insurance Commissioner is required to disapprove of proposed rate increases if they are excessive or discriminatory, and these are both,' Huckabee Sanders said in a statement. 'I'm calling on my Commissioner to follow the law, reject these insane rate increases, and protect Arkansans.'
The Hill
4 hours ago
- The Hill
Huge cuts to mRNA research spark fears about future pandemics
Health Secretary Robert F. Kennedy Jr.'s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will leave the United States unprepared for the next pandemic and other public health emergencies, public health experts warned. 'I've tried to be objective & non-alarmist in response to current HHS actions—but quite frankly this move is going to cost lives,' President Trump's former surgeon general Jerome Adams said in a post to X. 'mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions.' The first COVID-19 mRNA vaccines from Pfizer and Moderna hit the market in 2021, just a year after the virus first appeared. Vaccines typically take years to develop, but the mRNA shots were developed in record time due to a massive influx of funding from the first Trump administration, dubbed Operation Warp Speed. The COVID shots proved safe and effective, and helped bring about an end to the pandemic. Experts say mRNA technology has the potential to revolutionize treatments for evolving pathogens, especially bird flu, because the platform can be easily modified. On Tuesday, Kennedy cancelled $500 million worth of contracts related to mRNA vaccine research being funded by the Biomedical Advanced Research and Development Authority. Instead, he said the agency will focus on platforms with 'stronger safety records.' Public health experts point out that reviews of the hundreds of millions, if not billions, of doses of mRNA shots administered worldwide have found very few adverse events. 'It's pretty clear that the administration, or at least the secretary, has a political vendetta not just against vaccines but against mRNA in general,' said Jeff Coller, a professor of RNA biology and therapeutics at Johns Hopkins University. Coller said the move will put the U.S. behind other nations in biomedical research and sends a 'clear message' to scientists and the industry that it is not wise to invest in mRNA technology because if they do, they will likely not receive funding or approval from the federal government. Jennifer Nuzzo, a professor of epidemiology and director of the Pandemic Center at Brown University School of Public Health, told The Hill that the cancellation is a threat to national security, as it opens the U.S. to future public health emergencies caused by biological warfare. 'One of the ways that we deter that from happening is to say the United States is absolutely committed to preparedness,' Nuzzo said. 'When we take them off the table and leave nothing in their place, we basically signal to our adversaries that we are no longer interested in defending ourselves.' In the long run, Nuzzo said, winding down research efforts on mRNA vaccine platforms will stifle medical innovation coming out of the U.S., including new treatments for diseases like cancer. 'It's troubling on a number of fronts,' she said. MRNA vaccines work by sending instructions to cells to make a specific type of protein found on the outer membrane of a virus. The body's immune system is then able to recognize that protein as something foreign and will create antibodies to fight it. That same general approach could be used to help potentially vaccinate someone against a particular cancer, according to Nuzzo. 'Cancers have a genetic signature,' she said. 'We don't know what's going to happen but there are some preliminary studies that suggest it could be a very promising way to treat cancers.' None of the canceled contracts directly deal with cancer research, but the move will likely cause a chilling effect among researchers that ultimately impacts cancer-related work, said Michael Osterholm, founding director of the Center for Infectious Disease Research and Policy and member of the Vaccine Integrity Project. 'I think you're going to see anyone who is willing to invest in mRNA technology, pulling back, if not completely, getting out of this business,' he said. 'This is terribly unfortunate, given that we have a number of other infectious diseases for which this vaccine platform was being explored in terms of taking on other infectious diseases and including some cancer vaccines.' Kennedy is deeply skeptical of vaccines in general, and mRNA vaccines in particular. In 2021, he falsely said the mRNA COVID-19 vaccine was the 'deadliest vaccine ever made.' Kennedy has also been facing pressure from fellow anti-vaccine activists for not doing enough to keep mRNA vaccines off the market. He was criticized earlier this year when the Food and Drug Administration approved Moderna's updated COVID-19 vaccine, even though the agency limited its use in children. In a video posted to X on Tuesday, Kennedy falsely claimed mRNA shots don't protect against respiratory viruses and don't work if a virus mutates. 'One mutation and the vaccine becomes ineffective,' Kennedy said. Following the announcement, public health experts urged Congress to restore funding towards mRNA vaccine research, with some calling it an 'assault' on federal vaccine policy. 'The HHS Secretary continues a mindless assault on sound federal vaccine policy,' said Robert Steinbrook, director of the Public Citizen Health Reseach Group. 'The mRNA vaccine platform was essential to rapid vaccine development and deployment during the COVIVD-19 pandemic and remains essential to preparing for future public health emergencies.' But the full extent of Kennedy's move isn't known. A Moderna spokesperson told The Hill that they were not aware of any new award cancellations since their contract to help develop an H5N1 bird flu vaccine was canceled in May. Gritstone Bio, another company on the HHS list of cancelled contracts, ceased operations earlier this year after the company filed for bankruptcy in 2024. A spokesperson for Tiba Bio said HHS's decision to terminate their BARDA contract 'comes as a surprise' since its contract was for a therapeutic, not a vaccine, and it does not use mRNA technology. Instead, it uses a method called RNA interference, which the FDA approved to treat some diseases in 2018.
